Variables That Affect Results of PFA-100 in a Group of Healthy Blood Donors in the Slovak Population

1. Primary hemostasis [cit 2017-01-29]. Available on webpage: https://www.google.sk/search?q=primaryhemostasis+pictures&biw=1366&bih=622&noj=1&tbm=isch&tbo=u&source=univ&sa=X&ved=0ahUKEwiSoZek1fRAhVEtBoKHRRCA0kQ7AkINA#imgrc=nmJjzJyX3BW8LM%3ASearch in Google Scholar

2. Harrison P. Progress in the assessment of platelet function. Br J Haematol 2000; 111: 733-744.Search in Google Scholar

3. Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler CM, Larkin EC, Liles D, Nugent DJ. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998; 24: 195-202.10.1055/s-2007-995840Search in Google Scholar

4. Heilmann EJ, Kundu SK, Sio R, Garcia C, Gomez R, Christie DJ. Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA-100 system. Thromb Res 1997; 87: 159-164.10.1016/S0049-3848(97)00115-1Search in Google Scholar

5. Dalby MC, Davidson SJ, Burman JF, Davies SW. Diurnal variation in platelet aggregation with the PFA-100 platelet function analyzer. Platelets 2000; 11: 320-324.10.1080/0953710005014473111083456Search in Google Scholar

6. Lippi G, Franchini M, Brocco G, Manzato F. Influence of the ABO blood type on the platelet function analyzer PFA-100. Thromb Haemost 2001;85:369-370.10.1055/s-0037-1615707Search in Google Scholar

7. Lassila R. Platelet function tests in bleeding disorders. Semin Thromb Hemost 2016; 42(3): 185-190.10.1055/s-0036-157130726886396Search in Google Scholar

8. Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001; 138: 152-163.10.1067/mlc.2001.11740611528368Search in Google Scholar

9. Favaloro EJ. Clinical application of the PFA-100. Curr Opin Hematol 2002; 9: 407-415.10.1097/00062752-200209000-0000412172459Search in Google Scholar

10. Harrison P. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults. Br J Haematol 2005; 130: 3-10.10.1111/j.1365-2141.2005.05511.x15982339Search in Google Scholar

11. Eugster M, Reinhart WH. The influence of the haematocrit on primary haemostasis in vitro. Thromb Haemost 2005;94:1213-1218.10.1160/TH05-06-042416411396Search in Google Scholar

12. Franchini M. The platelet-function analyzer (PFA-100) for evaluating primary hemostasis. Hematology 2005; 10: 177-181.10.1080/1024533040002609716019466Search in Google Scholar

13. Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer - PFA-100. Semin Thromb Hemost 1995; 21: 106-12.10.1055/s-0032-13136127660150Search in Google Scholar

14. Favaloro EJ, Bonar R. External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update. Semin Thromb Hemost 2014; 40(2): 239-253.10.1055/s-0034-136584424497116Search in Google Scholar

15. Scavone M, Germanovich K, Fermia EA, et al. Usefulness of the INNOVANCE PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y12 receptor for adenosine diphosphate. Thromb Res 2014; 133(2): 254-256.10.1016/j.thromres.2013.11.02224331208Search in Google Scholar

16. PFA-100 System [cit. 2017/01/29]. Available on webpage: https://usa.healthcare.siemens.com/he-mostasis/systems/pfa-100Search in Google Scholar

17. Platelet Research Laboratory. Techniques availables [cit. 2017/01/29]. Available on webpage: http://- www.platelet-research.org/1/techniques_pfa.htmSearch in Google Scholar

18. Disorders of primary hemostasis: lecture 5 [cit. 2017/01/29]. Available on webpage: http:// www.sli-deshare.net/shababali1/lecture-5-fall-2014-pdfSearch in Google Scholar

19. Kenichi A Tanaka The Assessment of platelet function. Journal Compilation © 2006 LMS Trans - fusion Alternatives in Transfusion Medicine 2, 95- 105.Available on webpage: https://www.researchgate.net/publication/227625147The_assessmentofplateletfunction .10.1111/j.1778-428X.2006.00018.xSearch in Google Scholar

20. Favaloro EJ. Internal quality control and external quality assurance of platelet function tests. Semin Thromb Hemost 2009; 35(2): 139-149.10.1055/s-0029-122032219408187Search in Google Scholar

21. Zaffuto BJ, Coley GW, Connolly GC, et al. ABO immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion. Vox Sang 2016; 110(3): 219-226.10.1111/vox.1235426528766Search in Google Scholar

22. Peerschke EI, Castellone DD, Stroobants AK, et al. Reference range determination for whole- blood platelet aggregation using Multiplate analyzer. Am J Clin Pathol 2014; 142(5): 647-656.10.1309/AJCPP43SEYCBJLHJ25319980Search in Google Scholar

23. Poujoul C,Nurden A,Papponeau A, Heilmann E, Nurden P. Ultrastructural analysis of the distribution of von Willebrand factor and fibrinogen in platelet aggregates formed in the PFA-100. Platelets 1998; 9: 381-9.10.1080/0953710987645616793722Search in Google Scholar

24. Young-Uk Cho, Seongsoo Jang, Chan-Jeoung Park, . Variables that affect platelet function analyzer-100 (PFA-100) closure times and establishment of reference intervals in Korean adults. Ann Clin Lab Sci 2008 ;38(3):247-53.Search in Google Scholar

25. Harrison P, Robinson MS, Mackie IJ, Joseph J, McDonald SJ, Liesner R, Savidge GF, Pasi J, Machin SJ. Performance of the platelet function analyzer PFA-100 in testing abnormalities of primary haemostasis. Blood Coagul Fibrinolysis 1999; 10: 25-31.10.1097/00001721-199901000-0000410070832Search in Google Scholar

26. DiPaola J, Federici AB, Mannucci PM, Canciani MT, Kritzik M, Kunicki TJ, Nugent D. Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 1999; 93: 3578-82.10.1182/blood.V93.11.3578Search in Google Scholar

27. Marshall PW, Williams AJ, Dixon RM, Growcott JW, Warburton S, Armstrong J, Moores J. A compa - rison of the effects of aspirin on bleeding time measured using the Simplate method and closure time measured using the PFA-100, in healthy volunteers. Br J Clin Pharmacol 1997; 44: 151-5.10.1046/j.1365-2125.1997.00639.x20428139278200Search in Google Scholar